Anne Jacolot

1.4k total citations
20 papers, 239 citations indexed

About

Anne Jacolot is a scholar working on Pharmacology, Molecular Medicine and Oncology. According to data from OpenAlex, Anne Jacolot has authored 20 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 10 papers in Molecular Medicine and 5 papers in Oncology. Recurrent topics in Anne Jacolot's work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (4 papers). Anne Jacolot is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (13 papers), Antibiotic Resistance in Bacteria (10 papers) and Pneumonia and Respiratory Infections (4 papers). Anne Jacolot collaborates with scholars based in France. Anne Jacolot's co-authors include Olivier Petitjean, Olivier Mimoz, Kamran Samii, Michel Tod, Patrice Nordmann, Edouard Auvinet, Christophe Padoin, K. Louchahi, Samuel Bellais and C Richer and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, International Journal of Pharmaceutics and Intensive Care Medicine.

In The Last Decade

Anne Jacolot

20 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Jacolot France 10 113 100 45 35 30 20 239
Yangmin Hu China 13 67 0.6× 103 1.0× 80 1.8× 57 1.6× 22 0.7× 20 351
M A Gill United States 11 215 1.9× 135 1.4× 117 2.6× 16 0.5× 28 0.9× 22 366
Dawn Harper United States 8 115 1.0× 113 1.1× 44 1.0× 41 1.2× 78 2.6× 9 375
Jerry Altshuler United States 10 90 0.8× 57 0.6× 68 1.5× 17 0.5× 48 1.6× 24 278
C. Randall Marchbanks United States 8 177 1.6× 93 0.9× 125 2.8× 44 1.3× 27 0.9× 11 337
Annette Lubasch Germany 6 104 0.9× 58 0.6× 92 2.0× 41 1.2× 58 1.9× 9 218
Aniello Alfieri Italy 11 91 0.8× 125 1.3× 55 1.2× 28 0.8× 31 1.0× 32 275
Tania Mashiach Israel 8 90 0.8× 218 2.2× 105 2.3× 19 0.5× 28 0.9× 12 437
Alfred Chin United States 10 161 1.4× 86 0.9× 54 1.2× 14 0.4× 14 0.5× 30 349
Maria Sole Vallecoccia Italy 10 91 0.8× 109 1.1× 186 4.1× 20 0.6× 82 2.7× 15 420

Countries citing papers authored by Anne Jacolot

Since Specialization
Citations

This map shows the geographic impact of Anne Jacolot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Jacolot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Jacolot more than expected).

Fields of papers citing papers by Anne Jacolot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Jacolot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Jacolot. The network helps show where Anne Jacolot may publish in the future.

Co-authorship network of co-authors of Anne Jacolot

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Jacolot. A scholar is included among the top collaborators of Anne Jacolot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Jacolot. Anne Jacolot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tandjaoui-Lambiotte, Yacine, et al.. (2020). Viral transmission in asymptomatic cases of SARS-CoV-2 infection. Journal of Infection. 82(2). 282–327. 2 indexed citations
2.
Rigal, Marthe, Kader Chouahnia, A. Paix, et al.. (2020). Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer. Vaccines. 8(4). 730–730. 9 indexed citations
3.
Alloui, Chakib, et al.. (2019). Patients traités pour une hépatite C dans un bassin de population défavorisé : quelles particularités ?. Médecine et Maladies Infectieuses. 49(4). S35–S35. 1 indexed citations
4.
5.
6.
Padoin, Christophe, et al.. (2004). Apport du dosage plasmatique des aminoglycosides. Revue Française des Laboratoires. 2004(365). 27–34. 1 indexed citations
7.
Bellais, Samuel, et al.. (2002). Efficacy of β-Lactams for Treating Experimentally Induced Pneumonia Due to a Carbapenem-Hydrolyzing Metallo-β-Lactamase-Producing Strain of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 46(6). 2032–2034. 30 indexed citations
8.
Mimoz, Olivier, Anne Jacolot, Christophe Padoin, et al.. (2000). Efficacies of Imipenem, Meropenem, Cefepime, and Ceftazidime in Rats with Experimental Pneumonia Due to a Carbapenem-Hydrolyzing β-Lactamase-Producing Strain of Enterobacter cloacae. Antimicrobial Agents and Chemotherapy. 44(4). 885–890. 17 indexed citations
9.
Jacolot, Anne, Pascal Incagnoli, Alain Edouard, et al.. (1999). Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome. Intensive Care Medicine. 25(5). 486–491. 7 indexed citations
10.
Mimoz, Olivier, Anne Jacolot, Frédéric Laurent, et al.. (1999). Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum β -lactamase-producing strain of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 44(1). 91–97. 16 indexed citations
11.
Mimoz, Olivier, Anne Jacolot, Edouard Auvinet, et al.. (1998). Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Medicine. 24(10). 1047–1051. 51 indexed citations
12.
Mimoz, Olivier, Anne Jacolot, Christophe Padoin, et al.. (1998). Cefepime and amikacin synergy in vitro and in vivo against a ceftazidime-resistant strain of Enterobacter cloacae. Journal of Antimicrobial Chemotherapy. 41(3). 367–372. 16 indexed citations
13.
Mimoz, Olivier, Anne Jacolot, Nadia Hidri, et al.. (1998). Efficacies of Cefepime, Ceftazidime, and Imipenem Alone or in Combination with Amikacin in Rats with Experimental Pneumonia Due to Ceftazidime-Susceptible or -Resistant Enterobacter cloacae Strains. Antimicrobial Agents and Chemotherapy. 42(12). 3304–3308. 16 indexed citations
14.
Mimoz, Olivier, Anne Jacolot, Christophe Padoin, et al.. (1997). Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo. Journal of Antimicrobial Chemotherapy. 39(3). 363–369. 14 indexed citations
15.
Jacolot, Anne, et al.. (1996). Monitoring of 8-Methoxypsoralen During Extracorporeal Photochemotherapy: Evidence for a “First-Dose” Effect. Therapeutic Drug Monitoring. 18(3). 234–239. 1 indexed citations
16.
Jacolot, Anne, M. Tod, & Olivier Petitjean. (1996). Pharmacokinetic interaction between cefdinir and two angiotensin-converting enzyme inhibitors in rats. Antimicrobial Agents and Chemotherapy. 40(4). 979–982. 9 indexed citations
17.
Jacolot, Anne, et al.. (1996). Stability and compatibility of 2.5 mg/ml methotrexate solution in plastic syringes over 7 days. International Journal of Pharmaceutics. 128(1-2). 283–286. 9 indexed citations
18.
Mimoz, Olivier, Anne Jacolot, Christophe Padoin, et al.. (1996). Influence of experimental rat model of multiple organ dysfunction on cefepime and amikacin pharmacokinetics. Antimicrobial Agents and Chemotherapy. 40(3). 819–821. 8 indexed citations
19.
Petitjean, Olivier, Anne Jacolot, & Michel Tod. (1995). Pharmacologie des antifongiques azolés systémiques. Médecine et Maladies Infectieuses. 25. 14–26. 5 indexed citations
20.
Giudicelli, J. F., Alain Berdeaux, Edouard Auvinet, et al.. (1984). Attenuation by diltiazem of arterial baroreflex sensitivity in man. European Journal of Clinical Pharmacology. 26(6). 675–679. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yangmin Hu Breakdown of academic impact, for papers by M A Gill Breakdown of academic impact, for papers by Dawn Harper Breakdown of academic impact, for papers by Jerry Altshuler Breakdown of academic impact, for papers by C. Randall Marchbanks Breakdown of academic impact, for papers by Annette Lubasch Breakdown of academic impact, for papers by Aniello Alfieri Breakdown of academic impact, for papers by Tania Mashiach Breakdown of academic impact, for papers by Alfred Chin Breakdown of academic impact, for papers by Maria Sole Vallecoccia
Rankless by CCL
2026